Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenue	$ 737	$ 1,002	$ 1,990	$ 2,659
Cost of revenue	33	193	129	438
Gross profit	704	809	1,861	2,221
Operating expenses:
Sales and marketing expenses	4	22	12	77
General and administrative expenses	315	493	811	1,838
Research and development costs	53	80	160	402
Operating income (loss)	332	214	878	(96)
Gain (loss) from change in fair value of hybrid financial instruments	154	(1,369)	(3,077)	(2,542)
Gain (loss) from change in fair value of derivative liability - warrants	2	38	1	618
Gain (loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	(17)	29	(27)	273
Gain on extinguishment of Debt	0	0	0	4,247
Interest expense	(8)	0	(34)	0
Net income (loss)	$ 463	$ (1,088)	$ (2,259)	$ 2,500
Net income (loss) per common share:
Basic	$ 0	$ (0.001)	$ (0.000)	$ 0.003
Fully diluted	$ 0	$ (0.001)	$ (0.000)	$ 0.003
Weighted average number of common shares:
Basic	4,900,892,387	1,357,349,653	4,770,891,318	810,443,147
Fully diluted	4,939,324,087	1,357,349,653	4,770,891,318	848,874,847